Shire Specialty Pharmaceuticals President Mike Cola: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Company is looking to do deals in three therapeutic areas, Cola says.
You may also be interested in...
Astellas VP-Business Development Masaki Doi: An Interview With "The Pink Sheet" DAILY (Part 2 0f 2)
"The Pink Sheet" DAILY visited recently with Astellas Pharma VP-Business Development Masaki Doi at the company's headquarters in Tokyo to talk about the Japanese pharma's global licensing strategy and the changing paradigm of Japanese deal flow. This is the second of a two-part interview. (Part 1 was printed yesterday in PharmAsia News).
Astellas VP-Business Development Masaki Doi: An Interview With “The Pink Sheet” DAILY (Part 2 0f 2)
Exec talks about emerging markets in Asia, and how Astellas’ culture differs from other Japanese pharmas.
Astellas VP-Business Development Masaki Doi: An Interview With “The Pink Sheet” DAILY (Part 2 0f 2)
Exec talks about emerging markets in Asia, and how Astellas’ culture differs from other Japanese pharmas.